NCT02121782View on ClinicalTrials.gov

A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Influenza
Interventions
BIOLOGICAL

Quadrivalent influenza vaccine

GC3110A, 0.5ml, intramuscular, a single dosing at Day 1

BIOLOGICAL

Trivalent influenza vaccine

GC Flu Pre-filled Syringe Inj., 0.5ml, intramuscular, a single dosing at Day 1

Trial Locations (1)

Unknown

Korea University Guro Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY